Questionnaire
OtherTo prevalence of psychological, physical and sexual violence suffered or committed in a population of patients suffering from one or more addictions
NCT Number: NCT05536245
Addictions, whether to a substance or a behavior, are often associated with violence, but their role is not well known. Despite the publication of numerous studies demonstrating the influence of addictions in acts of violence, the exploration of violence in the context of addiction remains very limited. In order to fill this gap, teams members of the Addictopôle Occitanie in collaboration with a regional team are preparing the launch of a concrete longitudinal study to analyze the incidence of violence in populations suffering from addiction, but also to evaluate the need in terms of management of this violence.
Hypotheses: To analyze the prevalence of violence in populations suffering from addiction and the need for treatment of such violence using a robust protocol based on an anonymous questionnaire to assess the violence experienced or committed by a patient, taking into account his/her environment. This study would allow us to better understand the effects of addictions on the severity and frequency of violence, but also to implement concrete and adapted solutions in order to limit it. This study could lead to the creation of a regional Observatory of Violence related to Addictions.
Translated with www.DeepL.com/Translator (free version)
Looking for future studies?
Notify Me18 year–99 year
All sexes
Observational
Gaëlle SULTAN-TIHLL, Béziers, France
Study visits will be conducted in the following chronological order:
i. Inclusion/End Visit (IEV): D0.Eligible patients will have been identified by the investigator, and will be recruited in the Addictology Department during their usual visit.
The inclusion visit is carried out by an investigating physician who will confirm the patient's eligibility and verify his or her ability to answer the questionnaire. It will take place in the care center. It is part of the usual care.
During this visit, the investigator will:
ii. Self-questionnaire entry visit (Vfollow-up/end): from D0 to 18 months (part of the usual care). After inclusion, the subject has enough time (15-30 min) to fill in the questionnaire independently. If the subject asks for it, the doctor can give him an explanation or clarify the meaning of a question and let him answer it alone. After completing the questionnaire, the subject will have no further obligations in relation to the study.The patient will complete an electronic self-questionnaire independently.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patient consulting for the first time. Patient under court protection, guardianship or curatorship. Severe psychiatric disorders that have not been stabilized: (schizophrenia, bipolar disorders, etc.).
Severe neurological disorders that are incompatible with reliable data collection.
Minor patients. Pregnant women, parturients. People in emergency situations, people unable to express their consent.
To prevalence of psychological, physical and sexual violence suffered or committed in a population of patients suffering from one or more addictions
Time frame: Between Day1 and 18 Months
Frequency of each type of violent act.
Time frame: Between Day 1 and 18 Months
Number of positive responses
Time frame: Between Day 1 and 18 Months
Number of positive responses
Centre Hospitalier Universitaire de Nīmes
Other
Acronym: APREVIO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07085377
Addictology, Chemically-Induced Disorders
Bayonne, France
View Trial Details